PeptiDream Valuation Multiples

PeptiDream Overview

About PeptiDream

PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.

Founded

2006

HQ

Employees

83

Website

peptidream.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $169M

EBITDA: $9M

EV

$887M

Valuation Multiples

Multiples.vc

Start free trial

PeptiDream Financials

PeptiDream reported last 12-month revenue of $169M and EBITDA of $9M.

In the same LTM period, PeptiDream generated $96M in gross profit, $9M in EBITDA, and had net loss of ($3M).

PeptiDream P&L

In the most recent fiscal year, PeptiDream reported revenue of $120M and EBITDA of ($17M).

PeptiDream expects next 12-month revenue of XXX and NTM EBITDA of XXX

PeptiDream Stock Performance

PeptiDream has current market cap of $960M, and enterprise value of $887M.

PeptiDream's stock price is $7.43.

PeptiDream Valuation Multiples

PeptiDream trades at 5.2x EV/Revenue multiple, and 101.0x EV/EBITDA.

PeptiDream Financial Valuation Multiples

As of April 18, 2026, PeptiDream has market cap of $960M and EV of $887M.

Equity research analysts estimate PeptiDream's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

PeptiDream has a P/E ratio of (285.4x).

PeptiDream Margins & Growth Rates

PeptiDream's revenue in the last 12 month grew by 71%.

PeptiDream's revenue per employee in the last FY averaged $1.5M, while opex per employee averaged $0.9M for the same period.

PeptiDream's rule of 40 is 172% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

PeptiDream's rule of X is 390% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

PeptiDream Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

PeptiDream M&A Activity

PeptiDream acquired XXX companies to date.

Last acquisition by PeptiDream was on XXXXXXXX, XXXXX. PeptiDream acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

PeptiDream Investment Activity

PeptiDream invested in XXX companies to date.

PeptiDream made its latest investment on XXXXXXXX, XXXXX. PeptiDream invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).